Riverwater Partners LLC Merck & Co., Inc. Transaction History

Riverwater Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$123.8 - $132.96 $12,751 - $13,694	-103 Reduced 5.67%	1,712 $211,000
Q1 2024 Apr 18, 2024	SELL	$113.24 - $131.95 $91,044 - $106,087	-804 Reduced 30.7%	1,815 $239,000
Q4 2023 Jan 04, 2024	SELL	$100.18 - $109.02 $44,880 - $48,840	-448 Reduced 14.61%	2,619 $285,000
Q3 2023 Oct 18, 2023	BUY	$102.95 - $114.33 $315,747 - $350,650	3,067 New	3,067 $315,000
Q3 2022 Nov 08, 2022	BUY	$84.53 - $94.96 $996,270 - $1.12 Million	11,786 New	11,786 $1.02 Million

3,828

1.87B

15.5M

13.6M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $230B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Riverwater Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Riverwater Partners LLC with notifications on news.